Patents Assigned to Ranbaxy Laboratories Limited
  • Publication number: 20160287583
    Abstract: The present invention relates to oral dispersible compositions comprising a DPP-IV inhibitor and processes for their preparation. It further relates to a method of treating diabetes by administering said oral dispersible compositions.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 6, 2016
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Vinod Kumar ARORA, Rathinasabapathy VENKATESHWARAN, Sumit MADAN
  • Publication number: 20160185760
    Abstract: The present invention relates to a process of preparation of malic acid salt of sunitinib.(I).
    Type: Application
    Filed: February 25, 2011
    Publication date: June 30, 2016
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh SANWAL, Saridi Madhava Dileep KUMAR, Swargam SATHYANARAYANA, Rajesh Kumar THAPER, Mohan PRASAD
  • Patent number: 9150542
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of methanesulfonate salt of dabigatran etexilate. (Formula (I)). The present invention does not require the isolation of the dabigatran etexilate intermediate.
    Type: Grant
    Filed: September 2, 2013
    Date of Patent: October 6, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Anandam Vempali, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Patent number: 9145421
    Abstract: The present invention provides a process for the preparation of asenapine maleate of Formula (I), comprising: intra-molecular cyclization of the intermediate of Formula (II) to obtain the intermediate of Formula (III) using aluminium halide.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: September 29, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Ram Chander Aryan, Anamika Mishra, Pudi Giri Jagannadha Naidu, Ramnik Sharma
  • Patent number: 9132092
    Abstract: The present invention relates to a pharmaceutical composition comprising (i) 50% to 99% of doxycycline as an immediate-release portion; (ii) 1% to 50% of doxycycline as a controlled-release portion; and (iii) one or more pharmaceutically acceptable excipients; wherein the pharmaceutical composition provides a total daily dosage of 40 mg when administered once daily. It also relates to process for preparation of the pharmaceutical composition and its use for treating rosacea.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: September 15, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni
  • Publication number: 20150246899
    Abstract: The present invention relates to a process for the preparation of dabigatran etexilate. The present invention also relates to trifluoroacetate salt of dabigatran etexilate and a process for its preparation. The present invention further relates to crystalline Form I and crystalline Form II of trifluoroacetate salt of dabigatran etexilate and processes for their preparation. The present invention further relates to a process for the preparation of pharmaceutically acceptable salts, including methanesulfonate salt, of dabigatran etexilate.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 3, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anandam Vempali, Sudhir Singh Sanwal, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Patent number: 9107929
    Abstract: The invention relates to stable parenteral formulations of tigecycline and process of preparation thereof, wherein the formulation comprises an edetate, a pH modifying agent or an antioxidant, such that the formulation remains stable for at least 45 hours.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: August 18, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Bhaskar Chauhan, Vinod Kumar Arora, Jyoti Srivastava
  • Patent number: 9085592
    Abstract: The present invention relates to process for the preparation of fosamprenavir calcium.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: July 21, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Satish Manohar Bhoge, Prakash Kshirsagar, Santosh Richhariya, Kaptan Singh
  • Patent number: 9078830
    Abstract: The invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: July 14, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Paras Jain, Umesh Vinayakrao Barabde, Kanwarpreet Singh Bakshi, Rajan Kumar Verma, Romi Barat Singh
  • Publication number: 20150174071
    Abstract: The present invention relates to controlled-release pharmaceutical dosage forms comprising a solid dispersion of a poorly water-soluble or insoluble drug with improved solubility and thus improved dissolution in an aqueous medium. The invention further discloses a process of preparation of these controlled-release dosage forms.
    Type: Application
    Filed: August 1, 2012
    Publication date: June 25, 2015
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Sandeep Kumar Vats, Kalaiselvan Ramaraju, Romi Barat Singh
  • Publication number: 20150132378
    Abstract: The present invention relates to a multilayered coated tablet comprising at least three layers, i.e., first, second and third layer wherein the first and third layers contain at least one active pharmaceutical ingredient and the second layer is either a placebo or an immediate-release drug layer. Further, the tablet has a delayed-release coating, wherein the coating may contain one or more pore-forming agents and/or orifices on one or both sides. Furthermore, it may contain an immediate-release layer of the drug over the delayed-release coating layer. The present invention further relates to processes for preparing such a multilayered coated tablet.
    Type: Application
    Filed: June 29, 2012
    Publication date: May 14, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Murali Krishna Bhavarisetti, Kumaravel Vivek, Sreekanth Narravula, Romi Barat Singh
  • Publication number: 20150112085
    Abstract: The present invention relates to pure crystalline Form II of an L-malic acid salt of sunitinib and a process for its preparation. The invention further provides crystalline Form II of an L-malic acid salt of sunitinib having a purity of at least 97.0%. The invention also provides crystalline Form II of an L-malic acid salt of sunitinib substantially free of an anti-oxidant. The invention also provides crystalline Form II of L-malic acid salt of sunitinib which remains chemically pure on storage at 25° C.±2° C. and 40° C.±2° C. at a relative humidity of 60%±5% and 75%±5%, respectively, for at least 1 month.
    Type: Application
    Filed: January 6, 2014
    Publication date: April 23, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Hari Babu MATTA, Mahavir Singh KHANNA, Mohan PRASAD
  • Publication number: 20150111940
    Abstract: The present invention relates to an ascorbic acid salt of sunitinib and a process for its preparation. The present invention further provides a crystalline Form I of an L-ascorbic acid salt of sunitinib.
    Type: Application
    Filed: January 6, 2014
    Publication date: April 23, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Hari Babu MATTA, Mahavir Singh KHANNA, Mohan PRASAD
  • Publication number: 20150112083
    Abstract: The present invention provides a process for the preparation of asenapine maleate of Formula (I), comprising: intra-molecular cyclization of the intermediate of Formula (II) to obtain the intermediate of Formula (III) using aluminium halide.
    Type: Application
    Filed: July 17, 2012
    Publication date: April 23, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Ram Chander Aryan, Anamika Mishra, Pudi Giri Jagannadha Naidu, Ramnik Sharma
  • Patent number: 9000150
    Abstract: The present invention relates to a process for the preparation of pure meropenem trihydrate.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: April 7, 2015
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Prashant Kumar Sharma, Bhupendra Vashishta, Shailendra K. Singh, Neera Tiwari, Subhash Dhar
  • Publication number: 20150031647
    Abstract: The present invention relates to a taste-masked dispersible tablet comprising a drug, a cation exchange resin, and other pharmaceutically acceptable excipients, such that the said drug and the said cation exchange resin are present in an un-complexed form in the tablet. It further relates to a process for the preparation of the same.
    Type: Application
    Filed: February 21, 2013
    Publication date: January 29, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Vinod Kumar Arora, Jatin Khurana, Deepak Gaikwad
  • Publication number: 20150031732
    Abstract: The present invention provides a solid dispersion of febuxostat, processes for its preparation, pharmaceutical compositions comprising it and its use for the chronic management of hyperuricemia in patients with gout.
    Type: Application
    Filed: April 16, 2012
    Publication date: January 29, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Poonam Kaushik, Ram Thaimattam, Mohan Prasad
  • Publication number: 20150025080
    Abstract: The present invention provides processes for the preparation of amorphous form of sitagliptin dihydrogen phosphate. It also provides a solid dispersion of sitagliptin dihydrogen phosphate, including in the amorphous form, and processes for its preparation.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 22, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Poonam Kaushik, Ram Thaimattam, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20140377347
    Abstract: The present invention relates to an in-situ multilayered tablet comprising at least one polymer layers and at least one drug layers wherein the said layers are physically separated from each other. After coming in contact with biological and/or aqueous fluids at least one of the polymer layers rapidly swells and sticks to one or more drug layers to form an in-situ multilayered tablet. Further, the polymer layer may optionally comprise a drug. Furthermore, the present invention relates to the processes for preparing said in-situ multilayered tablets.
    Type: Application
    Filed: January 23, 2013
    Publication date: December 25, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Kumaravel Vivek, Anuj Kumar Fanda, Murali Krishna, Ravish Kumar Sharma, Kanwarpreet Singh Bakshi, Romi Barat Singh, Ajay Kumar Singla
  • Patent number: 8916716
    Abstract: The present invention relates to stable crystalline Form II of L-malic acid salt of sunitinib and its preparation.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: December 23, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana